Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011

In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobler, Claudia C., Korver, Sarah, Batbayar, Ochirbat, Nyamdulam, Batiargal, Oyuntsetseg, Sodnomdarjaa, Tsolmon, Bold, Surmaajav, Bazarragchaa, Bayarjargal, Byambaa, Marais, Ben J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517706/
https://www.ncbi.nlm.nih.gov/pubmed/26196504
http://dx.doi.org/10.3201/eid2108.141860
Descripción
Sumario:In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug susceptibility testing available to more people.

Ejemplares similares